Replies to post #236 on Hepion Pharmaceuticals Inc (HEPA)

[carbonfiltered]

Yes, but CTRV activates only in the liver. While TAF is less toxic on kidneys and bones than Viread, CTRV is far more less toxic. Either way, CTRV is definitely going to permeate the $3.5 billion dollar HBV market